Alex Dulovic

Reutlingen, BW 72770, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines.

Journal: Vaccines

Published: November 19, 2025

Lymphoid-Tissue-on-Chip Recapitulates Human Antibody Responses In Vitro.

Lymphoid-Tissue-on-Chip Recapitulates Human Antibody Responses In Vitro.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 21, 2025

Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike.

Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike.

Journal: Frontiers in immunology

Published: September 29, 2025

Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice.

Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice.

Journal: Frontiers in immunology

Published: July 29, 2025

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease.

Journal: Vaccines

Published: May 24, 2025

Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees.

Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 05, 2025

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

Journal: Vaccines

Published: October 02, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Journal: Alimentary pharmacology & therapeutics

Published: August 28, 2024

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.

Journal: Frontiers in immunology

Published: August 28, 2024

Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families.

Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families.

Journal: Scientific reports

Published: August 01, 2024

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.

Journal: Vaccines

Published: June 07, 2024

Characteristics Associated with COVID-19 Breakthrough Infections after Booster Vaccinations in Healthcare Workers: Insights from the TüSeRe:exact Study.

Characteristics Associated with COVID-19 Breakthrough Infections after Booster Vaccinations in Healthcare Workers: Insights from the TüSeRe:exact Study.

Journal: Journal of clinical medicine

Published: December 27, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026